{"id":538926,"date":"2021-09-15T21:03:04","date_gmt":"2021-09-16T01:03:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/"},"modified":"2021-09-15T21:03:04","modified_gmt":"2021-09-16T01:03:04","slug":"waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/","title":{"rendered":"Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals <\/b><\/p>\n<p><b>News Summary:<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><i>New LC-MS system delivers accurate and reproducible results for multi-attribute monitoring of biologics.<\/i><\/li>\n<li><i>Eliminates analyte-to-metal surface interactions greatly enhancing recovery of hard-to-detect sample analytes. <\/i><\/li>\n<li><i>Gives more scientists greater access to MS data to improve quality, reduce costs, and ultimately help get medicines to patients faster.<\/i><\/li>\n<\/ul>\n<p>MILFORD, Mass.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nWaters Corporation (NYSE:WAT) today introduced the Waters\u2122 <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.waters.com%2Fwaters%2Fen_GB%2FBioAccord-LC-MS-System-with-ACQUITY-Premier-for-Routine-Biotherapeutic-Analysis%25E2%2580%258B%2Fnav.htm%3Fcid%3D135087537%26locale%3Den_GB&amp;esheet=52490448&amp;newsitemid=20210915005862&amp;lan=en-US&amp;anchor=BioAccord%26%238482%3B+System+with+ACQUITY%26%238482%3B+Premier&amp;index=1&amp;md5=ffabf0deea34bade418adb1167712d70\">BioAccord\u2122 System with ACQUITY\u2122 Premier<\/a>, a combination of the Waters BioAccord System and the breakthrough ACQUITY Premier UPLC\u2122 with MaxPeak\u2122 High Performance Surface (HPS) technology. The integrated high-resolution LC-MS system simplifies multi-attribute monitoring of biotherapeutics by improving analyte recovery and assay-to-assay reproducibility so that regulated laboratories can get needed medicines to patients faster.\n<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20210915005862\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210915005862\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210915005862\/en\/905815\/4\/BioAccord_Premier_System_BSM_SM_CH-A_TUV_bottles.jpg\" alt=\"The Waters BioAccord System with ACQUITY Premier is an easy-to-deploy and operate LC-MS system for performing multi-attribute monitoring of biotherapeutics and gives more scientists access to mass spectrometrty data. It can greatly improve analyte recovery and assay-to-assay reproducibility so that companies can improve process and product quality, reduce costs and get needed medicines to patients faster. (Photo: Business Wire)\" \/><\/p>\n<p style=\"font-size:85%\">The Waters BioAccord System with ACQUITY Premier is an easy-to-deploy and operate LC-MS system for performing multi-attribute monitoring of biotherapeutics and gives more scientists access to mass spectrometrty data. It can greatly improve analyte recovery and assay-to-assay reproducibility so that companies can improve process and product quality, reduce costs and get needed medicines to patients faster. (Photo: Business Wire)<\/p>\n<\/div>\n<p>\n\u201cAs promising as next-generation biotherapeutics are, they can be difficult to characterize when they contain low-level analytes which strongly interact and bind to the internal metal surfaces of conventional LCs, making them almost impossible to detect,\u201d said Dr. Udit Batra, CEO and President, Waters Corporation. \u201cWhen it comes to analyzing biologics, information is currency and by solving the problem of analyte-to-metal interactions, the BioAccord System with ACQUITY Premier gives scientists a faster means of getting information about everything in their samples from the very first injection.\u201d\n<\/p>\n<p>\nThe compact, benchtop BioAccord System with ACQUITY Premier features MaxPeak HPS technology and the SmartMS\u2122-enabled ACQUITY RDa\u2122 mass detector allowing analysts of all abilities to monitor critical quality attributes of biotherapeutics and assess the processes that make them, all while decreasing risk, thanks to compliant-ready acquisition and data workflows that deliver consistent data quality from user-to-user and system-to-system.\n<\/p>\n<p>\nMaxPeak HPS technology is a hybrid organic\/inorganic surface technology that forms a barrier between the sample and the biocompatible metal surfaces of both the UPLC inlet and column. By mitigating, or eliminating altogether, non-specific adsorption, MaxPeak HPS offers many benefits, among them:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nup to a 300% increase in detector sensitivity for more accurate glycan profiling, important for monitoring process and product quality of biologics<sup>[1]<\/sup><\/li>\n<li>\ngreatly improved analyte recovery and assay sensitivity for the measurement of modified peptides and impurities that are undetectable by conventional means\n<\/li>\n<li>\nsharper peak shapes and greater peak capacity for more accurate analyte identification and data interpretation\n<\/li>\n<li>\ngreater reproducibility for separations prone to adsorptive losses meaning less re-work or troubleshooting, and more confidence in results\n<\/li>\n<li>\neliminates need for system passivation that wastes valuable sample material or ties up instrument cycles\n<\/li>\n<li>\neases the transfer of methods from site-to-site and from company-to-company\n<\/li>\n<\/ul>\n<p>\nWith automated set-up and guided workflows made possible with SmartMS technology, the BioAccord System with ACQUITY Premier is designed for easy deployment. Rapid system startup is enabled through the delivery of\u200b system and applications training with pre-defined biopharmaceutical methods for each key workflow. And, because regulatory compliance and data integrity is vital to many biopharmaceutical laboratories, the system is built on the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.waters.com%2Fwaters%2Fen_US%2Fwaters_connect%2Fnav.htm%3Fcid%3D135040165%26locale%3Den_US&amp;esheet=52490448&amp;newsitemid=20210915005862&amp;lan=en-US&amp;anchor=waters_connect%26%238482%3B&amp;index=2&amp;md5=7aaad36fe746b03f6084024850854e62\">waters_connect\u2122<\/a> informatics platform backed by an industry-leading compliant informatics architecture and the worldwide availability of professional qualification services. \u200b\n<\/p>\n<p>\nCustomer shipments of the BioAccord System with ACQUITY Premier are expected to begin at the end of this month.\n<\/p>\n<p><b>Additional Resources<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nLearn more about the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.waters.com%2Fwaters%2Fnav.htm%3Fcid%3D135087537&amp;esheet=52490448&amp;newsitemid=20210915005862&amp;lan=en-US&amp;anchor=BioAccord+System+with+ACQUITY+Premier&amp;index=3&amp;md5=35919eef3637b70ed9515988d3a62085\">BioAccord System with ACQUITY Premier<\/a><\/li>\n<li>\nRead the blog post: <span class=\"bwuline\"><i><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fblog.waters.com%2Fbioaccord-acquity-premier-lc-ms-detection&amp;esheet=52490448&amp;newsitemid=20210915005862&amp;lan=en-US&amp;anchor=BioAccord+System+with+ACQUITY+Premier%3A+Some+things+just+work+better+together&amp;index=4&amp;md5=b2a8fa7ff56a88c26d4f677e603afdd3\">BioAccord System with ACQUITY Premier: Some things just work better together<\/a><\/i><\/span><i>. <\/i><\/li>\n<li>\nConnect with Waters via <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fwaters%2Fmycompany%2F&amp;esheet=52490448&amp;newsitemid=20210915005862&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=5&amp;md5=2a7b0012ae8d4ed60ecb4063a2a43f61\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FWatersCorp&amp;esheet=52490448&amp;newsitemid=20210915005862&amp;lan=en-US&amp;anchor=Twitter&amp;index=6&amp;md5=500a3d98607194f8a6d0db239b146c97\">Twitter<\/a>, and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FWaters%2F&amp;esheet=52490448&amp;newsitemid=20210915005862&amp;lan=en-US&amp;anchor=Facebook&amp;index=7&amp;md5=8ad44366262533a0a82261b613bfcf11\">Facebook<\/a><\/li>\n<\/ul>\n<p><b>About Waters Corporation<\/b> (<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.waters.com&amp;esheet=52490448&amp;newsitemid=20210915005862&amp;lan=en-US&amp;anchor=www.waters.com&amp;index=8&amp;md5=07e788460a9c4739f17d7fe82dd012ee\">www.waters.com<\/a>)\n<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.waters.com%2Fnextgen%2Fus%2Fen.html&amp;esheet=52490448&amp;newsitemid=20210915005862&amp;lan=en-US&amp;anchor=Waters+Corporation&amp;index=9&amp;md5=445a000ffe417ddb57d5de4a7a583148\">Waters Corporation <\/a>(NYSE:WAT), the world&#8217;s leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,400 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.\n<\/p>\n<p><i>Waters, BioAccord, ACQUITY, SmartMS, RDa, UPLC, waters_connect and MaxPeak are trademarks of Waters Corporation.<\/i><\/p>\n<p><sup>1<\/sup>Typical results based on Waters lab tests of multiple compounds using both standard UPLC systems and columns compared with ACQUITY PREMIER system and columns featuring MaxPeak HPS. 300% increase in detector sensitivity of structurally similar phosphorylated mannose-6-glycans. Detection sensitivity may vary depending on the analytes being measured.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210915005862r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210915005862\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210915005862\/en\/<\/a><\/span><\/p>\n<p>\nBrian J. Murphy<br \/>\n<br \/>PR Manager, Corporate Communications<br \/>\n<br \/>Waters Corporation<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:brian_j_murphy@waters.com\">brian_j_murphy@waters.com<br \/>\n<\/a><br \/>+1 508-482-2614\n<\/p>\n<p><b>KEYWORDS:<\/b> Massachusetts United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Research Technology Medical Devices Software Biotechnology Hardware General Health Health Science Other Science<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210915005862\/en\/560437\/3\/Waters_logo_K.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210915005862\/en\/905815\/3\/BioAccord_Premier_System_BSM_SM_CH-A_TUV_bottles.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">The Waters BioAccord System with ACQUITY Premier is an easy-to-deploy and operate LC-MS system for performing multi-attribute monitoring of biotherapeutics and gives more scientists access to mass spectrometrty data. It can greatly improve analyte recovery and assay-to-assay reproducibility so that companies can improve process and product quality, reduce costs and get needed medicines to patients faster. (Photo: Business Wire)<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals News Summary: New LC-MS system delivers accurate and reproducible results for multi-attribute monitoring of biologics. Eliminates analyte-to-metal surface interactions greatly enhancing recovery of hard-to-detect sample analytes. Gives more scientists greater access to MS data to improve quality, reduce costs, and ultimately help get medicines to patients faster. MILFORD, Mass.&#8211;(BUSINESS WIRE)&#8211; Waters Corporation (NYSE:WAT) today introduced the Waters\u2122 BioAccord\u2122 System with ACQUITY\u2122 Premier, a combination of the Waters BioAccord System and the breakthrough ACQUITY Premier UPLC\u2122 with MaxPeak\u2122 High Performance Surface (HPS) technology. The integrated high-resolution LC-MS system simplifies multi-attribute monitoring of biotherapeutics by improving analyte recovery and assay-to-assay reproducibility so that regulated laboratories &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-538926","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals News Summary: New LC-MS system delivers accurate and reproducible results for multi-attribute monitoring of biologics. Eliminates analyte-to-metal surface interactions greatly enhancing recovery of hard-to-detect sample analytes. Gives more scientists greater access to MS data to improve quality, reduce costs, and ultimately help get medicines to patients faster. MILFORD, Mass.&#8211;(BUSINESS WIRE)&#8211; Waters Corporation (NYSE:WAT) today introduced the Waters\u2122 BioAccord\u2122 System with ACQUITY\u2122 Premier, a combination of the Waters BioAccord System and the breakthrough ACQUITY Premier UPLC\u2122 with MaxPeak\u2122 High Performance Surface (HPS) technology. The integrated high-resolution LC-MS system simplifies multi-attribute monitoring of biotherapeutics by improving analyte recovery and assay-to-assay reproducibility so that regulated laboratories &hellip; Continue reading &quot;Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-16T01:03:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20210915005862\/en\/905815\/4\/BioAccord_Premier_System_BSM_SM_CH-A_TUV_bottles.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals\",\"datePublished\":\"2021-09-16T01:03:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\\\/\"},\"wordCount\":877,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210915005862\\\/en\\\/905815\\\/4\\\/BioAccord_Premier_System_BSM_SM_CH-A_TUV_bottles.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\\\/\",\"name\":\"Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210915005862\\\/en\\\/905815\\\/4\\\/BioAccord_Premier_System_BSM_SM_CH-A_TUV_bottles.jpg\",\"datePublished\":\"2021-09-16T01:03:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210915005862\\\/en\\\/905815\\\/4\\\/BioAccord_Premier_System_BSM_SM_CH-A_TUV_bottles.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210915005862\\\/en\\\/905815\\\/4\\\/BioAccord_Premier_System_BSM_SM_CH-A_TUV_bottles.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/","og_locale":"en_US","og_type":"article","og_title":"Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals - Market Newsdesk","og_description":"Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals News Summary: New LC-MS system delivers accurate and reproducible results for multi-attribute monitoring of biologics. Eliminates analyte-to-metal surface interactions greatly enhancing recovery of hard-to-detect sample analytes. Gives more scientists greater access to MS data to improve quality, reduce costs, and ultimately help get medicines to patients faster. MILFORD, Mass.&#8211;(BUSINESS WIRE)&#8211; Waters Corporation (NYSE:WAT) today introduced the Waters\u2122 BioAccord\u2122 System with ACQUITY\u2122 Premier, a combination of the Waters BioAccord System and the breakthrough ACQUITY Premier UPLC\u2122 with MaxPeak\u2122 High Performance Surface (HPS) technology. The integrated high-resolution LC-MS system simplifies multi-attribute monitoring of biotherapeutics by improving analyte recovery and assay-to-assay reproducibility so that regulated laboratories &hellip; Continue reading \"Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-16T01:03:04+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20210915005862\/en\/905815\/4\/BioAccord_Premier_System_BSM_SM_CH-A_TUV_bottles.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals","datePublished":"2021-09-16T01:03:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/"},"wordCount":877,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20210915005862\/en\/905815\/4\/BioAccord_Premier_System_BSM_SM_CH-A_TUV_bottles.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/","name":"Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20210915005862\/en\/905815\/4\/BioAccord_Premier_System_BSM_SM_CH-A_TUV_bottles.jpg","datePublished":"2021-09-16T01:03:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20210915005862\/en\/905815\/4\/BioAccord_Premier_System_BSM_SM_CH-A_TUV_bottles.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20210915005862\/en\/905815\/4\/BioAccord_Premier_System_BSM_SM_CH-A_TUV_bottles.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/waters-bioaccord-system-with-acquity-premier-brings-greater-simplicity-accuracy-and-reproducibility-to-multi-attribute-monitoring-of-biopharmaceuticals-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538926","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=538926"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538926\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=538926"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=538926"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=538926"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}